共 1 条
[1]
P-357 Cyclooxygenase-2 (COX-2) inhibition in advanced non-small cell lung cancer (NSCLC): preliminary results of a phase II trial (THO-0054).[J].Iidiko Csiki;Adriana Gonzalez;David P. Carbone;Shiva Gautam;Alan Sandler;Norma Campbell;Ben Garcia;Jason Morrow;David H. Johnson.Lung Cancer.2003,

